Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.095 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.7 |